Uzbek Infant Receives Life-Saving Liver Transplant in Delhi Hospital
Delhi doctors successfully perform liver transplant on Uzbek infant with rare disorder.
Photo by Europeana
Doctors at Max Super Speciality Hospital in Delhi successfully treated a one-year-old boy from Uzbekistan suffering from Alagille syndrome, a rare genetic liver disorder, through a living donor liver transplant. The child's father donated part of his liver. The operation occurred last October, and the baby was discharged a month later.
The infant had developed jaundice soon after birth and was initially misdiagnosed with biliary atresia. After a detailed assessment, Alagille syndrome was confirmed. A successful transplant has given the child a chance at a healthier future.
Key Facts
Patient: One-year-old Uzbek boy
Condition: Alagille syndrome
Treatment: Living donor liver transplant
Donor: Child's father
Hospital: Max Super Speciality Hospital, Delhi
UPSC Exam Angles
GS Paper II: Issues relating to health, human resources.
Ethical considerations in organ donation and transplantation.
Government policies and programs related to healthcare infrastructure.
Visual Insights
Medical Tourism: Uzbekistan to Delhi
Shows the journey of the infant from Uzbekistan to Delhi for a life-saving liver transplant.
Loading interactive map...
More Information
Background
Alagille syndrome, the condition affecting the Uzbek infant, was first described in detail by Daniel Alagille, a French pediatrician, in 1969. However, earlier case reports hinted at the existence of this rare disorder. The genetic basis of Alagille syndrome, involving mutations in the JAG1 and NOTCH2 genes, was discovered much later, in the 1990s.
Liver transplantation, while a relatively recent advancement in medical history, has roots tracing back to experimental procedures in the mid-20th century. The first successful human liver transplant was performed by Thomas Starzl in 1967. The field has since evolved significantly with improvements in surgical techniques, immunosuppressant drugs, and donor selection criteria, making it a viable option for treating end-stage liver diseases like those caused by Alagille syndrome.
Latest Developments
Recent advancements in the treatment of Alagille syndrome include the development of targeted therapies aimed at managing specific symptoms and complications. For instance, drugs that reduce bile acid levels are increasingly used to alleviate the severe itching (pruritus) associated with the condition. Gene therapy is also being explored as a potential long-term solution, although it is still in the early stages of research.
In the broader context of organ transplantation, there's a growing focus on expanding the donor pool through initiatives like living donor programs and the use of marginal or extended criteria donors. Furthermore, research into xenotransplantation (transplanting organs from animals) is gaining momentum, offering a potential future solution to the organ shortage crisis.
Frequently Asked Questions
1. What is Alagille syndrome, and why is understanding it important for UPSC aspirants?
Alagille syndrome is a rare genetic disorder affecting the liver and other organs. Understanding rare diseases like this is important for UPSC aspirants as it highlights the challenges in healthcare access and the need for specialized medical interventions, which are relevant to social issues and public health topics in the syllabus.
2. What are the key facts about the Uzbek infant's liver transplant that are relevant for the UPSC Prelims exam?
For the UPSC Prelims, remember these key facts: the patient was a one-year-old from Uzbekistan, the condition was Alagille syndrome, the treatment was a living donor liver transplant, the donor was the child's father, and the hospital was Max Super Speciality Hospital in Delhi. Focus on rare diseases and international medical collaborations.
3. How does the successful liver transplant on the Uzbek infant impact common citizens in India?
This case highlights the availability of advanced medical treatments in India and promotes medical tourism. It also raises awareness about rare diseases and the importance of organ donation, potentially encouraging more people to consider becoming organ donors.
4. What recent developments related to Alagille syndrome are important to note?
Recent developments include targeted therapies to manage symptoms like itching and research into gene therapy as a potential long-term solution. These advancements showcase progress in treating rare genetic disorders.
5. What are some important dates/figures to remember regarding this news event for UPSC?
Remember October 2025 as the month of the transplant operation and '1' as the age of the infant. Also, remember Ajitabh Srivastava as a key personality.
6. What is the historical background of Alagille Syndrome?
Alagille syndrome was first described in detail by Daniel Alagille in 1969, with earlier case reports hinting at its existence. The genetic basis, involving mutations in the JAG1 and NOTCH2 genes, was discovered in the 1990s. This historical context helps understand the evolution of medical knowledge about rare diseases.
Practice Questions (MCQs)
1. Consider the following statements regarding Alagille syndrome: 1. It is a rare genetic disorder primarily affecting the liver, heart, and kidneys. 2. Mutations in the JAG1 and NOTCH2 genes are commonly associated with this syndrome. 3. Biliary atresia is the primary cause of Alagille syndrome. Which of the statements given above is/are correct?
- A.1 and 2 only
- B.2 and 3 only
- C.1 and 3 only
- D.1, 2 and 3
Show Answer
Answer: A
Statements 1 and 2 are correct. Alagille syndrome is a genetic disorder affecting multiple organ systems, and mutations in JAG1 and NOTCH2 are common causes. Statement 3 is incorrect because biliary atresia is a separate condition that can be misdiagnosed as Alagille syndrome, but it is not the cause of it.
2. In the context of organ transplantation in India, consider the following: 1. The Transplantation of Human Organs Act (THOA) was enacted in 1994 to regulate organ donation and transplantation activities. 2. The National Organ and Tissue Transplant Organization (NOTTO) functions as the apex body for coordinating and promoting organ donation. 3. Living donors are permitted to donate organs only to their immediate family members. Which of the statements given above is/are correct?
- A.1 and 2 only
- B.2 and 3 only
- C.1 and 3 only
- D.1, 2 and 3
Show Answer
Answer: A
Statements 1 and 2 are correct. THOA regulates organ donation, and NOTTO is the apex body. Statement 3 is incorrect because living donors can donate to non-relatives under certain conditions and with proper authorization.
3. Which of the following statements is NOT correct regarding liver transplantation?
- A.Living donor liver transplantation involves transplanting a portion of a healthy person's liver into the recipient.
- B.Immunosuppressant drugs are essential to prevent rejection of the transplanted liver.
- C.Liver transplantation is a curative treatment for all types of liver diseases.
- D.The first successful human liver transplant was performed in the late 1960s.
Show Answer
Answer: C
Option C is incorrect. While liver transplantation can be life-saving, it is not a curative treatment for all liver diseases. Some underlying conditions may persist or recur even after transplantation.
Related Articles
NCERT Textbook Revisions Spark Controversy: Key Changes and Concerns
High Court halts 'Kerala Story 2' release, asks CBFC review
Kerala Inaugurates Ayurveda Research Institute, Seeks Global Recognition
Telangana Government Plans Elaborate Iftar Dinner Events in Hyderabad
Women's Stories from Northeast India: Conflict, Resilience, and Identity